SCHEMBL25980994

SCHEMBL25980994

Cc1ccc(N(Cc2ccc(C(=O)NO)cc2)C(=O)N2CCN(c3ccc(C(=O)OCc4ccccc4)cc3)CC2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 6/20 0.43
STAT3 P40763 2/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC3 O15379 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
RORC P51449 1/20 0.38
HDAC1 Q13547 2/20 0.38
MEN1 O00255 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
GRM5 P41594 1/20 0.37
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979581 0.88 STAT3 (0.44) STAT3MAPTKDM4ESMN1; SMN2LMNA
SCHEMBL16211605 0.87 MAPT (0.44) CETPSTAT3MAPTKDM4ESMN1; SMN2
SCHEMBL16211424 0.83 MAPT (0.48) CETPMAPTKDM4EL3MBTL1SMN1; SMN2
SCHEMBL16211643 0.81 DRD2 (0.49) MAPTSMN1; SMN2LMNAMEN1KMT2A
SCHEMBL16211341 0.80 HDAC6 (0.47) STAT3HDAC6HDAC3HDAC11HDAC8
SCHEMBL16211513 0.80 STAT3 (0.46) STAT3SMN1; SMN2HPGDHDAC6HDAC3
SCHEMBL16211346 0.80 STAT3 (0.46) STAT3KDM4EHDAC6HDAC3HDAC11
SCHEMBL16211628 0.79 HDAC6 (0.53) STAT3HDAC6HDAC3HDAC11HDAC8
SCHEMBL16212023 0.77 MAPT (0.46) MAPTLMNAMEN1KMT2A
SCHEMBL16211541 0.76 LMNA (0.44) MAPTKDM4ETDP1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) NR1H2, CFTR, CYP11B2 CETP 258/4885STAT3 3635/4885MAPT 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.